Evidence map›Paper›PMID 38486038›Full record

ArticleScientific reports2024

Internet of Things enabled open source assisted real-time blood glucose monitoring framework.

Abubeker K M, Ramani R, Raja Krishnamoorthy, Sreenivasulu Gogula, Baskar S, Sathish Muthu, Girinivasan Chellamuthu, Kamalraj Subramaniam

Abstract read
In one paragraph

Article in Scientific reports, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Abubeker K MDepartment of Electronics and Communication Engineering, Amal Jyothi College of Engineering (Autonomous), Koovappally, Kerala, India. kmabubeker82@gmail.com.
Ramani RDepartment of Computer Science and Engineering, P.S.R Engineering College, Sivakasi, Tamilnadu, India.
Raja KrishnamoorthyDepartment of Electronics and Communication Engineering, Kalasalingam Academy of Research and Education, Krishnankoil, Tamilnadu, India.
Sreenivasulu GogulaDepartment of Computer Science and Engineering, (Data Science), Vardhaman College of Engineering, Shamshabad, Hyderabad, India.
Baskar SFaculty of Engineering, Department of Electronics and Communication Engineering, Karpagam Academy of Higher Education, Coimbatore, Tamilnadu, India.
Sathish MuthuDepartment of Orthopaedics, Government Medical College & Hospital, Karur, Tamilnadu, India.
Girinivasan ChellamuthuDepartment of Orthopaedics, Saveetha Medical College and Hospital, Saveetha Institute of Medical and Technical Sciences (SIMATS), Saveetha University, Chennai, Tamilnadu, India.
Kamalraj SubramaniamDepartment of Biomedical Engineering, Karpagam Academy of Higher Education, Coimbatore, Tamilnadu, India.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Regular monitoring of blood glucose levels is essential for the management of diabetes and the development of appropriate treatment protocols. The conventional blood glucose (BG) testing have an intrusive technique to prick the finger and it can be uncomfortable when it is a regular practice. Intrusive procedures, such as fingerstick testing has negatively influencing patient adherence. Diabetic patients now have an exceptional improvement in their quality of life with the development of cutting-edge sensors and healthcare technologies. intensive care unit (ICU) and pregnant women also have facing challenges including hyperglycemia and hypoglycemia. The worldwide diabetic rate has incited to develop a wearable and accurate non-invasive blood glucose monitoring system. This research developed an Internet of Things (IoT) - enabled wearable blood glucose monitoring (iGM) system to transform diabetes care and enhance the quality of life. The TTGOT-ESP32 IoT platform with a red and near-infrared (R-NIR) spectral range for blood glucose measurement has integrated into this wearable device. The primary objective of this gadget is to provide optimal comfort for the patients while delivering a smooth monitoring experience. The iGM gadget is 98.82 % accuracy when used after 10 hours of fasting and 98.04 % accuracy after 2 hours of breakfast. The primary objective points of the research were continuous monitoring, decreased risk of infection, and improved quality of life. This research contributes to the evolving field of IoT-based healthcare solutions by streaming real-time glucose values on AWS IoT Core to empower individuals with diabetes to manage their conditions effectively. The iGM Framework has a promising future with the potential to transform diabetes management and healthcare delivery.

Indexed as

Diabetes MellitusInternet of ThingsBlood GlucoseBlood Glucose Self-MonitoringFemaleHumansImmunoglobulin MPregnancyQuality of LifeBlood GlucoseImmunoglobulin M

Identifiers

PMID38486038
PMCPMC10940634

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.